Tags

Type your tag names separated by a space and hit enter

Micro needling: A novel therapeutic approach for androgenetic alopecia, A Review of Literature.
Dermatol Ther. 2020 11; 33(6):e14267.DT

Abstract

Androgenetic alopecia (AGA) is an androgen-dependent hereditary trait resulting in hair miniaturization. It is the most common type of alopecia in men and women. During the last years, multiple treatment modalities have been studied, but only topical minoxidil and finasteride have been approved by the US Food and Drug Administration. Microneedling (MN) is a minimally invasive technique that induces collagen formation, as well as growth factors production and neovascularization. Even though not many studies of MN in alopecia have been performed, it remains a favorable treatment modality; however, no standardized protocol for MN in hair loss has been proposed yet. Current evidence is not sufficient to allow a direct comparison with other therapies, but it shows promises to increase hair density, thickness, and quality of hair, especially when combined with other treatments or when used as a drug delivery system. This article aims to summarize the available literature regarding the use of MN alone or associated with other therapies for the treatment of androgenetic alopecia.

Authors+Show Affiliations

Dermatology Department, Univeristy Hospital ¨Dr. José Eleuterio González¨, Universidad Autónoma de Nuevo León, Monterrey, Mexico.Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.Dermatology Department, Univeristy Hospital ¨Dr. José Eleuterio González¨, Universidad Autónoma de Nuevo León, Monterrey, Mexico.Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.Dermatology Unit, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

32882083

Citation

Ocampo-Garza, Sonia Sofia, et al. "Micro Needling: a Novel Therapeutic Approach for Androgenetic Alopecia, a Review of Literature." Dermatologic Therapy, vol. 33, no. 6, 2020, pp. e14267.
Ocampo-Garza SS, Fabbrocini G, Ocampo-Candiani J, et al. Micro needling: A novel therapeutic approach for androgenetic alopecia, A Review of Literature. Dermatol Ther. 2020;33(6):e14267.
Ocampo-Garza, S. S., Fabbrocini, G., Ocampo-Candiani, J., Cinelli, E., & Villani, A. (2020). Micro needling: A novel therapeutic approach for androgenetic alopecia, A Review of Literature. Dermatologic Therapy, 33(6), e14267. https://doi.org/10.1111/dth.14267
Ocampo-Garza SS, et al. Micro Needling: a Novel Therapeutic Approach for Androgenetic Alopecia, a Review of Literature. Dermatol Ther. 2020;33(6):e14267. PubMed PMID: 32882083.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Micro needling: A novel therapeutic approach for androgenetic alopecia, A Review of Literature. AU - Ocampo-Garza,Sonia Sofia, AU - Fabbrocini,Gabriella, AU - Ocampo-Candiani,Jorge, AU - Cinelli,Eleonora, AU - Villani,Alessia, Y1 - 2020/09/28/ PY - 2020/07/22/received PY - 2020/08/23/revised PY - 2020/08/30/accepted PY - 2020/9/4/pubmed PY - 2021/5/12/medline PY - 2020/9/4/entrez KW - androgenetic alopecia KW - collagen induction therapy KW - dermaroller KW - hair loss KW - microneedling KW - needling dermabrasion KW - pattern hair loss SP - e14267 EP - e14267 JF - Dermatologic therapy JO - Dermatol Ther VL - 33 IS - 6 N2 - Androgenetic alopecia (AGA) is an androgen-dependent hereditary trait resulting in hair miniaturization. It is the most common type of alopecia in men and women. During the last years, multiple treatment modalities have been studied, but only topical minoxidil and finasteride have been approved by the US Food and Drug Administration. Microneedling (MN) is a minimally invasive technique that induces collagen formation, as well as growth factors production and neovascularization. Even though not many studies of MN in alopecia have been performed, it remains a favorable treatment modality; however, no standardized protocol for MN in hair loss has been proposed yet. Current evidence is not sufficient to allow a direct comparison with other therapies, but it shows promises to increase hair density, thickness, and quality of hair, especially when combined with other treatments or when used as a drug delivery system. This article aims to summarize the available literature regarding the use of MN alone or associated with other therapies for the treatment of androgenetic alopecia. SN - 1529-8019 UR - https://neuro.unboundmedicine.com/medline/citation/32882083/Micro_needling:_A_novel_therapeutic_approach_for_androgenetic_alopecia_A_Review_of_Literature_ L2 - https://doi.org/10.1111/dth.14267 DB - PRIME DP - Unbound Medicine ER -